Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin PBM Strategy in Anemic CABG Patients
NCT06542393Phase 2Recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of erythropoietin in anemia (3 arms), sponsored by Federal University of São Paulo. Primary endpoint: Mean number of units of Red Blood Cells. Started Jun 2024; status: recruiting.
02
Drugs
erythropoietin
03
Conditions
anemia
Beyond the preview
Go deeper on NCT06542393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06542393.